Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic Constipation
Public ClinicalTrials.gov record NCT00153140. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the safety and efficacy of extended polyethyleneglycol3350 use to tegaserod in patients with chronic constipation.
Study identification
- NCT ID
- NCT00153140
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 239 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2004
- Primary completion
- Sep 30, 2004
- Completion
- Not listed
- Last update posted
- Feb 6, 2013
Started 2004
United States locations
- U.S. sites
- 25
- U.S. states
- 14
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mobile | Alabama | 36693 | — |
| Not listed | Glendale | Arizona | 85306 | — |
| Not listed | Anaheim | California | 92801 | — |
| Not listed | Sacramento | California | 95825 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | Lake Worth | Florida | 33461 | — |
| Not listed | Largo | Florida | 33770 | — |
| Not listed | St. Petersburg | Florida | 33707 | — |
| Not listed | Laurel | Maryland | 20707 | — |
| Not listed | Brighton | Massachusetts | 02135 | — |
| Not listed | St Louis | Missouri | 63017 | — |
| Not listed | Raleigh | North Carolina | 27609 | — |
| Not listed | Raleigh | North Carolina | 27612 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Cincinnati | Ohio | 45236 | — |
| Not listed | Greer | South Carolina | 29651 | — |
| Not listed | Memphis | Tennessee | 38120 | — |
| Not listed | Austin | Texas | 78705 | — |
| Not listed | Dallas | Texas | 75234 | — |
| Not listed | Fort Worth | Texas | 76135 | — |
| Not listed | San Angelo | Texas | 76904 | — |
| Not listed | Salt Lake City | Utah | 84121 | — |
| Not listed | Newport News | Virginia | 23606 | — |
| Not listed | Norfolk | Virginia | 23502 | — |
| Not listed | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00153140, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 6, 2013 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00153140 live on ClinicalTrials.gov.